Exicure, Inc. (XCUR)
1.40
+0.03
(+2.19%)
USD |
NASDAQ |
Sep 11, 16:00
Exicure Enterprise Value : 7.206M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 7.206M |
| September 10, 2026 | 7.015M |
| September 09, 2026 | 7.398M |
| September 08, 2026 | 7.270M |
| September 04, 2026 | 6.250M |
| September 03, 2026 | 6.123M |
| September 02, 2026 | 6.505M |
| September 01, 2026 | 6.569M |
| August 31, 2026 | 6.633M |
| August 28, 2026 | 6.505M |
| August 27, 2026 | 7.270M |
| August 26, 2026 | 6.314M |
| August 25, 2026 | 5.868M |
| August 24, 2026 | 5.613M |
| August 21, 2026 | 5.613M |
| August 20, 2026 | 6.569M |
| August 19, 2026 | 7.525M |
| August 18, 2026 | 7.398M |
| August 17, 2026 | 7.079M |
| August 14, 2026 | 6.250M |
| August 13, 2026 | 6.633M |
| August 12, 2026 | 6.569M |
| August 11, 2026 | 7.206M |
| August 10, 2026 | 7.015M |
| August 07, 2026 | 6.856M |
| Date | Value |
|---|---|
| August 06, 2026 | 6.888M |
| August 05, 2026 | 7.908M |
| August 04, 2026 | 8.099M |
| August 03, 2026 | 8.354M |
| July 31, 2026 | 8.481M |
| July 30, 2026 | 8.29M |
| July 29, 2026 | 9.310M |
| July 28, 2026 | 9.374M |
| July 27, 2026 | 9.437M |
| July 24, 2026 | 9.501M |
| July 23, 2026 | 9.182M |
| July 22, 2026 | 9.501M |
| July 21, 2026 | 10.58M |
| July 20, 2026 | 10.33M |
| July 17, 2026 | 8.991M |
| July 16, 2026 | 8.609M |
| July 15, 2026 | 8.609M |
| July 14, 2026 | 9.246M |
| July 13, 2026 | 8.800M |
| July 10, 2026 | 9.437M |
| July 09, 2026 | 10.39M |
| July 08, 2026 | 9.119M |
| July 07, 2026 | 10.39M |
| July 06, 2026 | 10.97M |
| July 02, 2026 | 10.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -58.55M |
| Manhattan Scientifics, Inc. | -- |
| Century Therapeutics, Inc. | 269.22M |
| Absci Corp. | 1.211B |
| Celularity, Inc. | 109.20M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.121M |
| Total Expenses (Quarterly) | 1.121M |
| EPS Diluted (Quarterly) | -0.1759 |
| Earnings Yield | -93.06% |
| Normalized Earnings Yield | -82.51 |